The FDA has given the green light to a first-ever clinical trial to assess the ApoGraft technology for haploidentical bone marrow transplantations to be conducted at Washington University School of Medicine in St. Louis. Sponsor is Cellect Biotechnology Ltd., (NASDAQ:...